# Trade Mark Journal No.2025/028 11 July 2025

## UK00004227257 1 July 2025 (9,10,35,36,42,44)

Class 9
  Downloadable artificial intelligence software for use in medical research, clinical trials, and diagnostics; machine learning software for analysing neuroimaging data; software for generating synthetic healthcare datasets; data analysis and modelling software for personalised medicine and drug development; digital twin systems and predictive modelling platforms for use in clinical settings.
Class 10
  Medical imaging apparatus and instruments; diagnostic instruments for neurological and physiological analysis; AI-powered clinical diagnostic devices; computer-aided diagnostic instruments; electronic equipment for capturing, analysing, or visualising patient data and treatment response in clinical trials.
Class 35
  Business consultancy and advisory services relating to healthcare and artificial intelligence; strategic advisory for clinical development, commercialisation, and drug asset optimisation; data processing and business information services for healthcare institutions and pharmaceutical companies; consultancy in trial design, treatment strategy, and business operations.
Class 36
  Financial consultancy and strategic advisory relating to investment in healthcare and biotechnology; financial data analysis and modelling for clinical asset valuation; management of financial portfolios related to pharmaceutical and clinical trial assets; provision of information relating to healthcare and biotech finance.
Class 42
  Scientific and technological research in the fields of artificial intelligence, neuroscience, and healthcare; development of machine learning algorithms and generative models for clinical trial optimisation and medical diagnostics; provision of software as a service (SaaS) for disease prediction, trial simulation, and therapeutic modelling; research and development in interventional inference, physiological data analytics, and digital twin generation.
Class 44
  Medical and clinical diagnostic services based on artificial intelligence; personalised medicine services using AI-derived biomarkers and predictive analytics; healthcare analytics for patient stratification and trial readiness; AI-based interpretation of clinical and imaging data; planning and advisory services for individualised medicine and disease progression modelling.

Hologen Limited